欢迎来到天天文库
浏览记录
ID:53735929
大小:291.00 KB
页数:4页
时间:2020-04-21
《终末期肾病患者顺式阿曲库铵量效关系测定.pdf》由会员上传分享,免费在线阅读,更多相关内容在应用文档-天天文库。
1、982国际麻醉学与复苏杂志2013年11月第34卷第11期IntJAnesthResus,November2013,V0l_34,No.11论著·终末期肾病患者顺式阿曲库铵量效关系测定葛彦虎王宏月刘秀珍王恒林张斌王卓强【摘要】目的采用单次剂量注射法测定终末期肾病患者顺式阿曲库铵量效关系。方法选取接受肾移植的终末期肾病患者40例,按完全随机方法分为4组,每组10例,对4个剂量组患者按体重注射20、30、40、50txg/kg的顺式阿曲库铵。选取无神经肌肉病变的患者20例作为对照组,给予相同剂量的苯磺酸顺
2、式阿曲库铵。记录每个患者最大抑制效应,并对最大抑制效应进行概率转换,对应的肌松药剂量进行对数转换,用直线回归方法建立顺式阿曲库铵的剂量_反应曲线。结果终末期肾病患者顺式阿曲库铵50%有效剂量(ED,。)、75%有效剂量(ED)、90%有效剂量(ED)、95%有效剂量ED。分别为30.88、35.65、40.62、43.85~g/kg,无神经肌肉病变患者顺式阿曲库铵EDEDEDED分别为35.37、42.22、49.60、54.55ixg/kg,终末期肾病患者顺式阿曲库铵ED明显低于无神经肌肉病变患者E
3、D(P4、309HospitalofPLA,Beijing100091,ChinaCorrespondingauthor:LIUXiu~hen,Email:xiuzhenliuina.com.cn_【Abstract】ObjectiveTodeterminethedose-responsecurveofcisatracuriuminpatientswithend-stagerenaldisease.MethodsFortypatientswithendstagerenaldiseasewererandomlyd5、ividedintofourgroups(n=lO).thedoseofcisatracuriumwere20.30.40or50ixg/kgrespectively.Twentypatientswithnormalneuralandmuscularfunctionwererandomlydividedintofourgroupsandreceivedthesamedosespattern.Thedose-responsecurvewasdeterminedbysinglebolusofcisatra6、curiumundermidazolam-fentanylintravenousanesthesia.Neuromusculartransmissionmonitoringwasusedtomeasuretheblockeffectafterinjectionofcisatracurium,andtheresponsesweredefinedbytermsofthepercentagesofmaximumsuppressionintwitchresponse1oftrainoffouroftheadd7、uctorpoliciesmuscle.Afterlogarithmictransformation,thedose-responsecurveofcisatracuriumwasthenestablishedbylinearanalysis.ResultsTheED50,ED75,ED∞andED95ofcisatracuriuminpatientswithendstagekidneydiseasewere30.88,35.65,40.62,43.85ixg/kg,withnormalneurala8、ndmuscularfunctionwere35.37,42.22,49.60,54.55txg/kg,respectively,theED95ofcisatracuriuminpatientswithendstagekidneydiseasewassignificantlylowerthanthatinpatientswithnormalneuralandmuscularfuntion.ConclusionsPatientswithendstageki
4、309HospitalofPLA,Beijing100091,ChinaCorrespondingauthor:LIUXiu~hen,Email:xiuzhenliuina.com.cn_【Abstract】ObjectiveTodeterminethedose-responsecurveofcisatracuriuminpatientswithend-stagerenaldisease.MethodsFortypatientswithendstagerenaldiseasewererandomlyd
5、ividedintofourgroups(n=lO).thedoseofcisatracuriumwere20.30.40or50ixg/kgrespectively.Twentypatientswithnormalneuralandmuscularfunctionwererandomlydividedintofourgroupsandreceivedthesamedosespattern.Thedose-responsecurvewasdeterminedbysinglebolusofcisatra
6、curiumundermidazolam-fentanylintravenousanesthesia.Neuromusculartransmissionmonitoringwasusedtomeasuretheblockeffectafterinjectionofcisatracurium,andtheresponsesweredefinedbytermsofthepercentagesofmaximumsuppressionintwitchresponse1oftrainoffouroftheadd
7、uctorpoliciesmuscle.Afterlogarithmictransformation,thedose-responsecurveofcisatracuriumwasthenestablishedbylinearanalysis.ResultsTheED50,ED75,ED∞andED95ofcisatracuriuminpatientswithendstagekidneydiseasewere30.88,35.65,40.62,43.85ixg/kg,withnormalneurala
8、ndmuscularfunctionwere35.37,42.22,49.60,54.55txg/kg,respectively,theED95ofcisatracuriuminpatientswithendstagekidneydiseasewassignificantlylowerthanthatinpatientswithnormalneuralandmuscularfuntion.ConclusionsPatientswithendstageki
此文档下载收益归作者所有